Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death

Journal of Neural Transmission

Volumn 118, Issue 11, 2011, Pages 1585-1598

  Park, Bokyung ^a   Oh, Chang Ki ^a   Choi, Won Seok ^a   Chung, In Kwon ^a   Youdim, Moussa B H ^a   Oh, Young J ^a  

^a Yonsei University   (South Korea)

Author keywords

6 hydroxydopamine; Dopaminergic neurons; Microarray; MKP1; Sequestosome 1

Indexed keywords

COMPLEMENTARY DNA; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; OXIDOPAMINE; SEQUESTOSOME 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RAT; VALIDATION PROCESS;

ANIMALS; CELL DEATH; CELL LINE; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; MICE; NERVE DEGENERATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 84855216000     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0710-x     Document Type: Article

References (59)

1. Alkharouf NW, Klink VP, Chouikha IB, Beard HS, Macdonald MH, Meyer S, Knap HT, Khan R, Matthews BF (2006) Timecourse microarray analyses reveal global changes in gene expression of susceptible Glycine max (soybean) roots during infection by Heterodera glycines (soybean cyst nematode). Planta 224(4): 838-852 (Pubitemid 44286375)
2. Ardley HC, Scott GB, Rose SA, Tan NG, Robinson PA (2004) UCHL1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease. J Neurochem 90(2):379-391 (Pubitemid 38938224)
3. Baranzini SE (2004) Gene expression profiling in neurological disorders: toward a systems-level understanding of the brain. Neuromolecular Med 6(1):31-51 (Pubitemid 41359116)
4. Bassilana F, Mace N, Li Q, Stutzmann JM, Gross CE, Pradier L, Benavides J, Menager J, Bezard E (2005) Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease. Neurobiol Dis 20(1): 93-103 (Pubitemid 41219206)
5. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171(4):603-614 (Pubitemid 41668720)
6. Bottenstein JE, Sato GH (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76(1):514-517 (Pubitemid 9106659)
7. Bove J, Prou D, Perier C, Przedborski S (2005) Toxin-induced models of Parkinson's disease. NeuroRx 2(3):484-494 (Pubitemid 41444882)
8. Ceru S, Layfield R, Zavasnik-Bergant T, Repnik U, Kopitar-Jerala N, Turk V, Zerovnik E (2010) Intracellular aggregation of human stefin B: confocal and electron microscopy study. Biol Cell 102(6):319-334
9. Choi HK, Won LA, Kontur PJ, Hammond DN, Fox AP, Wainer BH, Hoffmann PC, Heller A (1991) Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res 552(1):67-76
10. Choi WS, Eom DS, Han BS, Kim WK, Han BH, Choi EJ, Oh TH, Markelonis GJ, Cho JW, Oh YJ (2004) Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem 279(19):20451-20460 (Pubitemid 38623492)
11. Choi BH, Hur EM, Lee JH, Jun DJ, Kim KT (2006) Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase 1 contributes to glutamate-induced neuronal cell death. J Cell Sci 119(Pt 7):1329-1340
12. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39(6):889-909 (Pubitemid 37130207)
13. Dawson TM, Ko HS, Dawson VL (2010) Genetic animal models of Parkinson's disease. Neuron 66(5):646-661
14. D'Haeseleer P (2005) How does gene expression clustering work? Nat Biotechnol 23(12):1499-1501
15. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95(25):14863-14868 (Pubitemid 29003722)
16. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283-2301
17. Ginsberg SD, Elarova I, Ruben M, Tan F, Counts SE, Eberwine JH, Trojanowski JQ, Hemby SE, Mufson EJ, Che S (2004) Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem Res 29(6):1053-1064 (Pubitemid 39023481)
18. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140(6):918-934
19. Grunblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G, Li J, Ravid R, Roggendorf W, Riederer P, Youdim MB (2004) Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 111(12):1543-1573 (Pubitemid 40068786)
20. Han BS, Hong HS, Choi WS, Markelonis GJ, Oh TH, Oh YJ (2003) Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. J Neurosci 23(12):5069-5078 (Pubitemid 36793234)
21. Hauser MA, Li YJ, Xu H, Noureddine MA, Shao YS, Gullans SR, Scherzer CR, Jensen RV, McLaurin AC, Gibson JR, Scott BL, Jewett RM, Stenger JE, Schmechel DE, Hulette CM, Vance JM (2005) Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Arch Neurol 62(6):917-921 (Pubitemid 40973453)
22. Holtz WA, Turetzky JM, O'Malley KL (2005) Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death. Antioxid Redox Signal 7(5-6):639-648 (Pubitemid 40563202)
23. Ishii T, Yanagawa T, Yuki K, Kawane T, Yoshida H, Bannai S (1997) Low micromolar levels of hydrogen peroxide and proteasome inhibitors induce the 60-kDa A170 stress protein in murine peritoneal macrophages. Biochem Biophys Res Commun 232(1):33-37 (Pubitemid 27211914)
24. Javoy F, Sotelo C, Herbet A, Agid Y (1976) Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system. Brain Res 102(2):201-215
25. Jeon BS, Jackson-Lewis V, Burke RE (1995) 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration 4(2):131-137
26. Jin BK, Iacovitti L (1995) Dopamine differentiation factors produce partial motor recovery in 6-hydroxydopamine lesioned rats. Neurobiol Dis 2(1):1-12
27. Kuusisto E, Suuronen T, Salminen A (2001) Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem Biophys Res Commun 280(1):223-228 (Pubitemid 32917500)
28. Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62(12):1241-1253 (Pubitemid 37494193)
29. Lee YM, Park SH, Shin DI, Hwang JY, Park B, Park YJ, Lee TH, Chae HZ, Jin BK, Oh TH, Oh YJ (2008) Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. J Biol Chem 283(15):9986-9998
30. Li M, Zhou JY, Ge Y, Matherly LH, Wu GS (2003) The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation. J Biol Chem 278(42):41059-41068 (Pubitemid 37280929)
31. Liu YX, Wang J, Guo J, Wu J, Lieberman HB, Yin Y (2008) DUSP1 is controlled by p53 during the cellular response to oxidative stress. Mol Cancer Res 6(4):624-633 (Pubitemid 351521844)
32. Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson KD (1990) Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161(2):153-160 (Pubitemid 20195792)
33. Martinez-Vicente M, Cuervo AM (2007) Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 6(4):352-361 (Pubitemid 46367949)
34. Miller RM, Federoff HJ (2006) Microarrays in Parkinson's disease: asystematic approach. NeuroRx 3(3):319-326 (Pubitemid 43946714)
35. Mufson EJ, Counts SE, Che S, Ginsberg SD (2006) Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease. Prog Brain Res 158:197-222 (Pubitemid 44486372)
36. Nagaoka U, Kim K, Jana NR, Doi H, Maruyama M, Mitsui K, Oyama F, Nukina N (2004) Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions. J Neurochem 91(1):57-68 (Pubitemid 39314937)
37. Nakagawa T, Schwartz JP (2004) Gene expression profiles of reactive astrocytes in dopamine-depleted striatum. Brain Pathol 14(3):275-280 (Pubitemid 39095989)
38. Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G (2010) Missing pieces in the Parkinson's disease puzzle. Nat Med 16(6):653-661
39. Park KA, Yun N, Shin DI, Choi SY, Kim H, Kim WK, Kanakura Y, Shibayama H, Oh YJ (2011) Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain. J Neural Transm 118(3):433-444
40. Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM (1995) Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67(3):631-647
41. Reich M, Ohm K, Angelo M, Tamayo P, Mesirov JP (2004) GeneCluster 2.0: an advanced toolset for bioarray analysis. Bioinformatics 20(11):1797-1798 (Pubitemid 39162057)
42. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP (2006) GenePattern 2.0. Nat Genet 38(5):500-501
43. Riccio M, Di Giaimo R, Pianetti S, Palmieri PP, Melli M, Santi S(2001) Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Exp Cell Res 262(2):84-94 (Pubitemid 32980247)
44. Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, Greene LA (2002) Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci 22(24):10690-10698 (Pubitemid 36005143)
45. Ryu EJ, Angelastro JM, Greene LA (2005) Analysis of gene expression changes in a cellular model of Parkinson disease. Neurobiol Dis 18(1):54-74 (Pubitemid 40092896)
46. Sauer H, Oertel WH (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59(2):401-415 (Pubitemid 24098798)
47. Seta KA, Kim R, Kim HW, Millhorn DE, Beitner-Johnson D (2001) Hypoxia-induced regulation of MAPK phosphatase-1 as identified by subtractive suppression hybridization and cDNA microarray analysis. J Biol Chem 276(48):44405-44412
48. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100(16):9440-9445 (Pubitemid 37033947)
49. Sun H, Charles CH, Lau LF, Tonks NK (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75(3):487-493 (Pubitemid 23335074)
50. Swarzenski BC, Tang L, Oh YJ, O'Malley KL, Todd RD (1994) Morphogenic potentials of D2, D3, and D4 dopamine receptors revealed in transfected neuronal cell lines. Proc Natl Acad Sci USA 91(2):649-653
51. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, Golub TR (1999) Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 96(6):2907-2912 (Pubitemid 29148817)
52. Turk V, Stoka V, Turk D (2008) Cystatins: biochemical and structural properties, and medical relevance. Front Biosci 13:5406-5420
53. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98(9):5116-5121 (Pubitemid 32397092)
54. Tyedmers J, Mogk A, Bukau B (2010) Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 11(11): 777-788
55. Westerlund M, Hoffer B, Olson L (2010) Parkinson's disease: exit toxins, enter genetics. Prog Neurobiol 90(2):146-156
56. Wu ZL, O'Kane TM, Scott RW, Savage MJ, Bozyczko-Coyne D (2002) Protein tyrosine phosphatases are up-regulated and participate in cell death induced by polyglutamine expansion. J Biol Chem 277(46):44208-44213 (Pubitemid 36157852)
57. Yang H, Wu GS (2004) p53 Transactivates the phosphatase MKP1 through both intronic and exonic p53 responsive elements. Cancer Biol Ther 3(12):1277-1282 (Pubitemid 41350966)
58. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, Denk H (2002) p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 160(1):255-263 (Pubitemid 34052286)
59. Zhen X, Torres C, Cai G, Friedman E (2002) Inhibition of protein tyrosine/mitogen-activated protein kinase phosphatase activity is associated with D2 dopamine receptor supersensitivity in a rat model of Parkinson's disease. Mol Pharmacol 62(6):1356-1363 (Pubitemid 35403830)